共 399 条
[31]
Arase Y(2007)Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C J Med Virol 79 1095-527
[32]
Tsubota A(2010)Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection Hepatology 52 518-207
[33]
Chayama K(1997)New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a J Clin Microbiol 35 201-735
[34]
Kumada H(2009)Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels J Hepatol 50 729-1490
[35]
Kawanishi M(2007)Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection J Med Virol 79 1485-1402
[36]
Tsukuma H(1998)Risk factors for hepatocellular carcinoma, its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group Hepatology 27 1394-438
[37]
Hiyama T(2009)Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis Hepatol Res 39 432-147
[38]
Tanaka S(2003)Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis Liver Int 23 143-877
[39]
Nakao M(2010)Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy Hepatol Res 40 870-271
[40]
Yabuuchi T(2011)Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C J Gastroenterol 46 790-undefined